Clinical Trial Update: Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma [Phase 3]

View source ↗

Summary

Clinical trial comparing surgery to a combined treatment with curettage and imiquimod for nodular basal cell carcinoma (Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nodular Basal Cell Carcinoma

Drugs mentioned

• Curettage
• Imiquimod (imiquimod)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Nodular Basal Cell Carcinoma | Phase 3 | Status: UNKNOWN